MLC1501

Moleac Pte Ltd. · Phase 2 active Small molecule

At a glance

Generic name	MLC1501
Sponsor	Moleac Pte Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (PHASE2)
MLC1501 Study Assessing Efficacy in STROke Recovery (PHASE2, PHASE3)
Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MLC1501 CI brief — competitive landscape report
MLC1501 updates RSS · CI watch RSS
Moleac Pte Ltd. portfolio CI